Seeding the exception: A flight to safety and back again
Sitting at the bottom, few of us would have predicted public and private markets hitting all-time highs less than a year later.
We saw record capital deployed into startups in 2020 and no slowdown in financings.
The seed-stage exception
But the story isn’t that simple. While venture investing across the board was hitting all-time highs, activity was skewed to later stage and follow on financings.
Many of us seed investors felt the pace of deals accelerate. In reality, the number of seed financings hit its lowest since 2016. Capital deployed was down too, but to a lesser extent.
Similar to 2016, the phrase on the tip of everyone’s tongue was “flight to quality.” (Flight to quality meaning more capital into fewer, presumably better, companies.)
Interestingly, these “higher-quality” companies didn’t command higher prices.
For example, in 2016, round sizes increased by 40% but prices only rose by 10%. Dilution for the median company jumped from approximately 20% to 25% in 2016, where it stuck for the next four years! ( Dilution = Round size / (Round size + Pre$ Value))
When COVID-19 hit, round sizes grew by 10% but valuations fell by 7%, different from the trends we saw at the later stage.
Furthermore, we saw this phenomenon hit companies across the spectrum. It wasn’t only COVID-headwind companies that took on extra dilution.